Direct Killing of Target Cells by HO-1
%Specific 51Cr Release From Target Cells . | |||
---|---|---|---|
51Cr-Labeled Auto LCL . | 51Cr-Labeled DR53 (−) LCL . | 51Cr-Labeled Auto LCL + Unlabeled DR53 (−) LCL3-150 . | 51Cr-Labeled DR53 (−) LCL + Unlabeled Auto LCL3-151 . |
61.3 | −3.6 | 61.6 | 1.1 |
%Specific 51Cr Release From Target Cells . | |||
---|---|---|---|
51Cr-Labeled Auto LCL . | 51Cr-Labeled DR53 (−) LCL . | 51Cr-Labeled Auto LCL + Unlabeled DR53 (−) LCL3-150 . | 51Cr-Labeled DR53 (−) LCL + Unlabeled Auto LCL3-151 . |
61.3 | −3.6 | 61.6 | 1.1 |
The 51Cr release assay was performed in the presence of 51Cr-labeled DEK-CAN peptide-loaded autologous LCL and unlabeled peptide-loaded HLA-DR53− allogeneic LCL.
The 51Cr release assay was performed in the presence of51Cr-labeled DEK-CAN peptide-loaded HLA-DR53−allogeneic LCL and unlabeled peptide-loaded autologous LCL.